Sweroside intervenes with vascular endothelial dysfunction in hypertensive rats by regulating FOXO1 expression

doi:10.12307/2023.198

Abstract

Abstract: BACKGROUND: Sweroside can regulate cellular oxidative stress, but its role in hypertension-induced oxidative damage of endothelial cells remains unclear.
OBJECTIVE: To investigate whether sweroside regulates hypertension-induced vascular endothelial dysfunction by regulating Forkhead box O1 (FOXO1) expression.
METHODS: (1) In vivo: The renal aorta constriction method was used to establish a hypertensive rat model. Forty male Sprague-Dawley rats were randomly divided into four groups: sham group, hypertension group, hypertension+25 mg/kg sweroside group, and hypertension+50 mg/kg sweroside group. TUNEL staining was used to detect the apoptosis of rat thoracic aorta endothelial cells. (2) In vitro: 50 μmol/L H2O2 was used to stimulate human umbilical vein endothelial cells to establish a cell oxidative damage model. Damaged cells were divided into control group, H2O2 group, H2O2+10, 20, or 40 μmol/L sweroside groups, H2O2+Vector group (negative control), H2O2+pcDNA-FOXO1 group, H2O2+40 μmol/L sweroside+Scramble group (negative control), and H2O2+40 μmol/L
sweroside+si-FOXO1 group. MTT and flow cytometry were used to detect cell proliferation and apoptosis, respectively. ELISA was used to detect the levels of angiotensin II, malondialdehyde, and nitric oxide levels in rat serum and human umbilical vein endothelial cells, as well as vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and E-selection levels in rat thoracic aorta tissues and human umbilical vein endothelial cells. RT-qPCR and western blot were used to detect the mRNA and protein expression of FOXO1 in rat thoracic aorta tissues and human umbilical vein endothelial cells.
RESULTS AND CONCLUSION: (1) In vivo: compared with the sham group, blood pressure and apoptosis were significantly increased (P < 0.05), the expression levels of FOXO1 mRNA and protein were significantly reduced (P < 0.05), the contents of angiotensin II, malondialdehyde, vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and E-selectin were significantly increased (P < 0.05), and the content of nitric oxide was significantly reduced (P < 0.05) in hypertensive rats. Sweroside could improve vascular dysfunction in hypertensive rats in a dose-dependent manner. (2) In vitro: compared with the control group, cell proliferation, FOXO1 expression and nitric oxide content were significantly reduced (P < 0.05), and cell apoptosis and malondialdehyde, vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and E-selection contents were significantly increased (P < 0.05) in the H2O2 group. Sweroside treatment or FOXO1 overexpression could improve the dysfunction of human umbilical vein endothelial cells induced by H2O2, and the interference of FOXO1 could reverse the effect of sweroside. To conclude, sweroside can improve vascular endothelial dysfunction in hypertensive rats by promoting FOXO1 expression.

Key words: sweroside, FOXO1, hypertension, oxidative stress, vascular endothelial dysfunction

CLC Number:

Zhang Xiqian, Tan Gaofeng, Sun Xiaoze, Pang Xin, Han Yu. Sweroside intervenes with vascular endothelial dysfunction in hypertensive rats by regulating FOXO1 expression[J]. Chinese Journal of Tissue Engineering Research, 2023, 27(23): 3628-3634.

Figures/Tables 3

References

[1] LI Y, YANG L, WANG L, et al. Burden of hypertension in China: A nationally representative survey of 174,621 adults.Int J Cardiol. 2017;227:516-523.
[2] OLIVEROS E, PATEL H, KYUNG S, et al. Hypertension in older adults: Assessment, management, and challenges. Clin Cardiol. 2020;43(2):99-107.
[3] MILLS KT, STEFANESCU A, HE J. The global epidemiology of hypertension. Nature Reviews Nephrology. 2020;16(4):223-237.
[4] Touyz RM, Rios FJ, Alves-Lopes R, et al. Oxidative stress: a unifying paradigm in hypertension. Can J Cardiol. 2020;36(5):659-670.
[5] TOUYZ RM, ANAGNOSTOPOULOU A, CAMARGO L, et al. Vascular biology of superoxide-generating NADPH oxidase 5 (Nox5)- implications in hypertension and cardiovascular disease. Antioxid Redox Signal. 2019;30(7):1027-1040.
[6] MA LQ, YU Y, CHEN H, et al. Sweroside Alleviated Aconitine-Induced Cardiac Toxicity in H9c2 Cardiomyoblast Cell Line. Front Pharmacol. 2018;9:1138.
[7] YANG G, JANG JH, KIM SW,et al. Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome. Int J Mol Sci. 2020;21(8):2790.
[8] WEI S, CHEN G, HE W, et al. Inhibitory effects of secoiridoids from the roots of Gentiana straminea on stimulus-induced superoxide generation, phosphorylation and translocation of cytosolic compounds to plasma membrane in human neutrophils. Phytother Res. 2012;26(2):168-173.
[9] LI J, ZHAO C, ZHU Q, et al. Sweroside Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Oxidative Stress and Pyroptosis Partially via Modulation of the Keap1/Nrf2 Axis. Front Cardiovasc Med. 2021;8:650368.
[10] DHARANEESWARAN H, ABID MR, YUAN L, et al. FOXO1-mediated activation of Akt plays a critical role in vascular homeostasis. Circ Res. 2014;115(2):238-251.
[11] JIAN D, WANG Y, JIAN L, et al. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. Theranostics. 2020;10(20):8939-8956.
[12] GRAVES DT, MILOVANOVA TN. Mucosal Immunity and the FOXO1 Transcription Factors. Front Immunol. 2019;10:2530.
[13] LIU X, CAO K, LV W, et al. Punicalagin attenuates endothelial dysfunction by activating FoxO1, a pivotal regulating switch of mitochondrial biogenesis. Free Radic Biol Med. 2019;135:251-260.
[14] WANG R, DONG Z, LAN X, et al. Sweroside Alleviated LPS-Induced Inflammation via SIRT1 Mediating NF-κB and FOXO1 Signaling Pathways in RAW264.7 Cells. Molecules. 2019;24(5):872.
[15] NATALIN HM, GARCIA AF, RAMALHO LN, et al. Resveratrol improves vasoprotective effects of captopril on aortic remodeling and fibrosis triggered by renovascular hypertension. Cardiovasc Pathol. 2016;25(2):116-119.
[16] TIAN Z, LIANG M. Renal metabolism and hypertension. Nat Commun. 2021;12(1):963.
[17] DAIBER A, CHLOPICKI S. Revisiting pharmacology of oxidative stress and endothelial dysfunction in cardiovascular disease: Evidence for redox-based therapies. Free Radic Biol Med. 2020;157:15-37.
[18] MIDAOUI AE, FANTUS IG, BOUGHROUS AA, et al. Beneficial Effects of Alpha-Lipoic Acid on Hypertension, Visceral Obesity, UCP-1 Expression and Oxidative Stress in Zucker Diabetic Fatty Rats. Antioxidants. 2019;8(12):648.
[19] GRIENDLING KK, CAMARGO LL, RIOS FJ, et al. Oxidative stress and hypertension. Circ Res. 2021;128(7):993-1020.
[20] NASH KM, SCHIEFER IT, SHAH ZA. Development of a reactive oxygen species-sensitive nitric oxide synthase inhibitor for the treatment of ischemic stroke.Free Radic Biol Med. 2018;115:395-404.
[21] CHEN L, JIANG M. Hypotensive Effect of Magnolin on Spontaneously Hypertensive Rats by Reversing Nitric Oxide Synthase Uncoupling. Revista Brasileira de Farmacognosia. 2022;32(1):65-73.
[22] PICKERING RJ. Oxidative Stress and Inflammation in Cardiovascular Diseases. Antioxidants (Basel). 2021;10(2):171.
[23] MARZIANO C, GENET G, HIRSCHI KK. Vascular endothelial cell specification in health and disease. Angiogenesis. 2021;24(2):213-236.
[24] WILSON C, ZHANG X, BUCKLEY C, et al. Increased Vascular Contractility in Hypertension Results From Impaired Endothelial Calcium Signaling. Hypertension. 2019;74(5):1200-1214.
[25] SILVA I, FIGUEIREDO R, RIOS D. Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation. Int J Mol Sci. 2019;20(14):3458.
[26] LIAO L, GONG L, ZHOU M, et al. Leonurine Ameliorates Oxidative Stress and Insufficient Angiogenesis by Regulating the PI3K/Akt-eNOS Signaling Pathway in H2O2-Induced HUVECs.Oxid Med Cell Longev. 2021;2021:9919466.
[27] ZHUANG T, LIU J, CHEN X, et al. Endothelial Foxp1 Suppresses Atherosclerosis via Modulation of Nlrp3 Inflammasome Activation. Circ Res. 2019;125(6):590-605.
[28] HUANG S, SHAO T, LIU H, et al. SIRT6 mediates MRTF-A deacetylation in vascular endothelial cells to antagonize oxLDL-induced ICAM-1 transcription. Cell Death Discov. 2022;8(1):96.
[29] WANG S, SHI M, LI J, et al. Endothelial cell–derived exosomal circHIPK3 promotes the proliferation of vascular smooth muscle cells induced by high glucose via the miR-106a-5p/Foxo1/Vcam1 pathway. Aging (Albany NY). 2021;13(23):25241-25255.
[30] CHEN L, YIN Y, LIU G. Metformin alleviates bevacizumab-induced vascular endothelial injury by up-regulating GDF15 and activating the PI3K/AKT/FOXO/PPARγ signaling pathway. Ann Transl Med. 2021;9(20):1547.
[31] LIU S, LAI L, ZUO Q, et al. PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis. J Mol Cell Cardiol. 2014;72:28-38.
[32] WANG J, HU JQ, SONG YJ, et al. 2′-Fucosyllactose Ameliorates Oxidative Stress Damage in d-Galactose-Induced Aging Mice by Regulating Gut Microbiota and AMPK/SIRT1/FOXO1 Pathway. Foods. 2022;11(2):151.
[33] IANNI A, KUMARI P, TARIGHI S, et al. An Insight into Giant Cell Arteritis Pathogenesis: Evidence for Oxidative Stress and SIRT1 Downregulation. Antioxidants (Basel). 2021;10(6):885.